STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Cardlytics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Cardlytics, Inc. (CDLX) filed a Form 144 notice reporting a proposed sale of 68,260 common shares through Fidelity Brokerage Services with an aggregate market value of $76,806.15. The filing lists the number of shares outstanding as 53,236,901 and indicates an approximate sale date of 08/18/2025 on NASDAQ. The securities were acquired as restricted stock vesting from the issuer on 08/15/2025 and the payment nature is noted as compensation.

The filer also reported a prior sale on 07/02/2025 of 6,725 shares for gross proceeds of $11,987.99. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

Insights

TL;DR This Form 144 reports a routine officer/insider sale of vested restricted stock with no additional disclosures.

The notice documents a proposed sale of 68,260 common shares via Fidelity with an aggregate market value of $76,806.15 and notes a prior sale of 6,725 shares for $11,987.99. The shares were acquired as restricted stock vesting from the issuer and the filing contains the required attestation about material non-public information. The filing does not disclose any earnings, financing, litigation, or other events beyond the equity sales themselves.

TL;DR The filing is a standard insider sale notice tied to vested compensation; it contains no governance irregularities or additional disclosures.

The Form 144 lists the transaction details, broker, acquisition method (restricted stock vesting), and the seller's attestation regarding material information. No departures from standard disclosure practices are indicated within the notice.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Cardlytics' Form 144 filed for CDLX report?

The filing reports a proposed sale of 68,260 common shares with aggregate market value of $76,806.15 to be sold on 08/18/2025 via Fidelity on NASDAQ.

How were the shares acquired that are being sold according to the Form 144?

The shares were acquired on 08/15/2025 as restricted stock vesting from the issuer, and the nature of payment is listed as compensation.

Has the filer sold Cardlytics shares recently before this proposed sale?

Yes. The filing lists a prior sale on 07/02/2025 of 6,725 common shares for gross proceeds of $11,987.99.

What outstanding share count does the Form 144 list for Cardlytics?

The filing lists 53,236,901 shares outstanding.

Which broker is named in the Form 144 for the planned sale?

The broker listed is Fidelity Brokerage Services LLC, address 900 Salem Street, Smithfield, RI 02917.
Cardlytics

NASDAQ:CDLX

CDLX Rankings

CDLX Latest News

CDLX Latest SEC Filings

CDLX Stock Data

61.62M
52.46M
2.95%
45.79%
14.27%
Advertising Agencies
Services-computer Programming, Data Processing, Etc.
Link
United States
ATLANTA